RBC raises Vertex Pharmaceuticals target price to $600 from $576
VRTX•RBC raised its target price for Vertex Pharmaceuticals to $600 from $576.
Related News
SS&C flags operational challenges as retail access to private markets expands
SSNC•
Global markets were already fragile. Big AI bets could break them
SPY•
Marriott: Jefferies raises target price to $478 from $429
MAR•
Principal Financial Group target price cut to $105 from $106
PFG•
Nasdaq price objective raised to $135 from $133
NDAQ•